Back to search results

Understanding Cardiogenic Shock Management and Outcomes

This study is an international registry looking at how cardiogenic shock (a serious condition where your heart can't pump enough blood to meet your body's needs) is currently managed and what happens to patients over time. It will gather information from 500 people with cardiogenic shock, including those with heart attacks or severe heart failure, at four major hospitals. The goal is to better understand what factors lead to good or bad outcomes for these patients. The main thing they will be looking at is how many patients survive after one year. This study is not testing a new treatment, but rather observing current care to help design better studies in the future.

Study design
This is an observational study, meaning researchers will collect information about current care without giving new treatments. It plans to include 500 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed to measure survival at 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05185492

Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock

Recruiting
Not specifiedAges 18+Observational
STAVROS G DRAKOS
~500 participants
Updated 2026-03-20 on ClinicalTrials.gov

At a glance

Recruiting sites
3 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Survival
Measured over 1 year

Conditions

Cardiogenic Shock
Acute Myocardial Infarction

Explore related trials

Acute Myocardial InfarctionCardiogenic ShockHeart FailurePulmonary Embolism

NCT05185492

Where you'd take part

This study runs at 3 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Cleveland Clinic Florida

    Weston, Floridastudy coordinator listed

    Recruiting

  • Inova Heart and Vascular Institute

    Falls Church, Virginiastudy coordinator listed

    Recruiting

  • University of Toronto

    Toronto, Ontario, Canadastudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Stavros Drakos, M.D. · PRINCIPAL_INVESTIGATOR · University of Utah

Who to contact

John Kirk
[email protected]
801-585-2944
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Primary diagnosis of cardiogenic shock at time of index evaluation; including acute myocardial infarction- and acute decompensated heart failure-cardiogenic shock phenotypes
Patients with cardiac arrest complicating cardiogenic shock and those with massive pulmonary embolism with right ventricular cardiogenic shock will also be eligible for the registry

Exclusion

Patients with shock not due to primary cardiac etiology will be excluded. These include septic, hemorrhagic, and anaphylactic shock.

What this trial measures

  • Survival1 year

    Percentage of participants alive at analysis time points